Pharma

Global Human Growth Hormone Market Opportunities and Forecast 2020-2027

  • DLR2902
  • 12 February, 2022
  • Pharma & Healthcare
  • Pages: 120
  • Global
Global Human Growth Hormone Market, By Route of Administration (Intravenous, Subcutaneous, Intramuscular, Oral) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Clinics) By Indication (Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, Other), and opportunities and forecast 2020-2027

Human Growth Hormone Market Overview

The global Human Growth Hormone market is expected to rise at a considerable rate in the forthcoming years on the back of the increase in awareness about the effectiveness of growth hormones and the growing prevalence of chronic diseases.
 
Human growth hormone is a peptide hormone that is responsible for cell creation, growth stimulation, and cell regeneration in the human body. It plays an important part in the human body's growth. Human growth hormones have a lot of advantages; thus, they'll have a lot of growth potential over the next few years. The rising prevalence of human development problems has raised awareness of the significance of therapy among a huge portion of the global population, resulting in a significant increase in the market for human growth hormones.
 
The creation of a strong research and development program is important to the success of the human growth hormone market. The participants in the human growth hormone market put a lot of money into these operations in order to find new formulations that will help them increase their profits. The players are also engaged in expansion initiatives, which are expected to raise the market for human growth hormones even more.

Report Metric Details
Market size available for years 2019–2027
Base year considered 2019
Forecast period 2020–2027
Forecast unit Value (USD Million)
Segments covered Route of Administration, Distribution Channel, Indication, and Region.
Regions covered North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA)
Companies covered AMerck KGaA, Pfizer Inc., Eli Lilly and Company, Novartis AG, Novo Nordisk A/S, Anhui Anke Biotechnology (Group) Co., Ltd, Biopartners GmbH, Ipsen S.A, GeneScience Pharmaceuticals Co., Ltd., Roche Holdings, Inc.


Covid-19 Impact on Human Growth Hormone Market
 
In addition, the current Human Growth Hormone Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Human Growth Hormone Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.

The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.

Human Growth Hormone Market Segment Overview



According to Route of Administration, Subcutaneous is a major segment in the global Human Growth Hormone market. The subcutaneous method is becoming more popular since it results in a large increase in growth rates and a low incidence of antibody formation. Furthermore, for prolonged growth hormone therapy, the subcutaneous route is highly preferable. By Distribution Channel, Hospital Pharmacy is one of the largest segments in the global market. A number of hospital pharmacies are distributing medications due to the high cost of human growth hormone drugs. In addition, governments in various countries are investing heavily in the establishment of modern healthcare facilities and hospitals, which is pushing the distribution of growth hormone medications through hospital pharmacies.
 
Human Growth Hormone Market, By Route of Administration
·       Intravenous
·       Subcutaneous
·       Intramuscular
·       Oral

Human Growth Hormone Market, By Distribution Channel
·       Hospital Pharmacy
·       Retail Pharmacy
·       Online Pharmacy
·       Clinics

Human Growth Hormone Market, By Indication
·       Growth Hormone Deficiency
·       Turner Syndrome
·       Idiopathic Short Stature
·       Prader-Willi Syndrome
·       Other
 
Human Growth Hormone Regional Overview

Based on the region, North America held the largest share in the global Human Growth Hormone market. The presence of key market players, as well as the FDA's approval of growth hormone for commercial use, are propelling the market forward. As well, the market in the Asia Pacific is projected to enlarge at a higher level in the coming years. India, China, and Australia are all contributing to the region's growth. Furthermore, the growing number of persons suffering from growth hormone deficiency creates a potential for the region's leading companies

Human Growth Hormone Market, By Geography

·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)

Human Growth Hormone Market, Key Players

·       Merck KGaA
·       Pfizer Inc.
·       Eli Lilly and Company
·       Novartis AG
·       Novo Nordisk A/S
·       Anhui Anke Biotechnology (Group) Co., Ltd
·       Biopartners GmbH
·       Ipsen S.A
·       GeneScience Pharmaceuticals Co., Ltd.
·       Roche Holdings, Inc.

Frequently Asked Questions (FAQ) :

Q1. What are the driving factors for the global Human Growth Hormone market?

A. The increase in awareness about the effectiveness of growth hormones and the growing prevalence of chronic diseases are important factors that positively impact the growth of the market

Q2. Which Segments are covered in the global Human Growth Hormone market report?

A. Route of Administration, Distribution Channel, Indication, and Region. these segments are covered in the global Human Growth Hormone market report.

Q3. Which segment is projected to hold the largest share in the global Human Growth Hormone market?

A. Subcutaneous segments are projected to hold the largest share in the global Human Growth Hormone market.

Q4. Which region holds the largest share in the global Human Growth Hormone market?

A. North America held the largest share in the global Human Growth Hormone market.

Q5. Which are the prominent players in the global Human Growth Hormone market?

A. Merck KGaA, Pfizer Inc., Eli Lilly and Company, Novartis AG, Novo Nordisk A/S, Anhui Anke Biotechnology (Group) Co., Ltd, Biopartners GmbH, Ipsen S.A, GeneScience Pharmaceuticals Co., Ltd., Roche Holdings, Inc. are some key players in the global Human Growth Hormone market.
Human Growth Hormone Market Study Global Market Analysis, Insights and Forecast, 2020-2027

    1. Introduction

    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions

    2. Executive Summary

      3. Market Dynamics

      • 3.1. Market Drivers
      • 3.2. Market Restraints
      • 3.3. Market Opportunities

      4. Key Insights

      • 4.1. Key Emerging Trends – For Major Countries
      • 4.2. Latest Technological Advancement
      • 4.3. Regulatory Landscape
      • 4.4. Industry SWOT Analysis
      • 4.5. Porters Five Forces Analysis

      5. Global Human Growth Hormone Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 5.1. Key Findings / Summary
      • 5.2. Market Analysis, Insights and Forecast – By Route of Administration
        • 5.2.1. Intravenous
        • 5.2.2. Subcutaneous
        • 5.2.3. Intramuscular
        • 5.2.4. Oral
      • 5.3. Market Analysis, Insights and Forecast – By Distribution Channel
        • 5.3.1. Hospital Pharmacy
        • 5.3.2. Retail Pharmacy
        • 5.3.3. Online Pharmacy
        • 5.3.4. Clinics
      • 5.4. Market Analysis, Insights and Forecast – By Indication
        • 5.4.1. Growth Hormone Deficiency
        • 5.4.2. Turner Syndrome
        • 5.4.3. Idiopathic Short Stature
        • 5.4.4. Prader-Willi Syndrome
        • 5.4.5. Other
      • 5.5. Market Analysis, Insights and Forecast – By Region
        • 5.5.1. North America
        • 5.5.2. Europe
        • 5.5.3. Asia Pacific
        • 5.5.4. Latin America, Middle East and Africa

      6. North America Human Growth Hormone Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 6.1. Key Findings / Summary
      • 6.2. Market Analysis, Insights and Forecast – By Route of Administration
        • 6.2.1. Intravenous
        • 6.2.2. Subcutaneous
        • 6.2.3. Intramuscular
        • 6.2.4. Oral
      • 6.3. Market Analysis, Insights and Forecast – By Distribution Channel
        • 6.3.1. Hospital Pharmacy
        • 6.3.2. Retail Pharmacy
        • 6.3.3. Online Pharmacy
        • 6.3.4. Clinics
      • 6.4. Market Analysis, Insights and Forecast – By Indication
        • 6.4.1. Growth Hormone Deficiency
        • 6.4.2. Turner Syndrome
        • 6.4.3. Idiopathic Short Stature
        • 6.4.4. Prader-Willi Syndrome
        • 6.4.5. Other
      • 6.5. Market Analysis, Insights and Forecast – By Country
        • 6.5.1. U.S.
        • 6.5.2. Canada

      7. Europe Human Growth Hormone Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 7.1. Key Findings / Summary
      • 7.2. Market Analysis, Insights and Forecast – By Route of Administration
        • 7.2.1. Intravenous
        • 7.2.2. Subcutaneous
        • 7.2.3. Intramuscular
        • 7.2.4. Oral
      • 7.3. Market Analysis, Insights and Forecast – By Distribution Channel
        • 7.3.1. Hospital Pharmacy
        • 7.3.2. Retail Pharmacy
        • 7.3.3. Online Pharmacy
        • 7.3.4. Clinics
      • 7.4. Market Analysis, Insights and Forecast – By Indication
        • 7.4.1. Growth Hormone Deficiency
        • 7.4.2. Turner Syndrome
        • 7.4.3. Idiopathic Short Stature
        • 7.4.4. Prader-Willi Syndrome
        • 7.4.5. Other
      • 7.5. Market Analysis, Insights and Forecast – By Country
        • 7.5.1. UK
        • 7.5.2. Germany
        • 7.5.3. France
        • 7.5.4. Italy
        • 7.5.5. Spain
        • 7.5.6. Russia
        • 7.5.7. Rest of Europe

      8. Asia Pacific Human Growth Hormone Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 8.1. Key Findings / Summary
      • 8.2. Market Analysis, Insights and Forecast – By Route of Administration
        • 8.2.1. Intravenous
        • 8.2.2. Subcutaneous
        • 8.2.3. Intramuscular
        • 8.2.4. Oral
      • 8.3. Market Analysis, Insights and Forecast – By Distribution Channel
        • 8.3.1. Hospital Pharmacy
        • 8.3.2. Retail Pharmacy
        • 8.3.3. Online Pharmacy
        • 8.3.4. Clinics
      • 8.4. Market Analysis, Insights and Forecast – By Indication
        • 8.4.1. Growth Hormone Deficiency
        • 8.4.2. Turner Syndrome
        • 8.4.3. Idiopathic Short Stature
        • 8.4.4. Prader-Willi Syndrome
        • 8.4.5. Other
      • 8.5. Market Analysis, Insights and Forecast – By Country
        • 8.5.1. China
        • 8.5.2. India
        • 8.5.3. Japan
        • 8.5.4. Australia
        • 8.5.5. South East Asia
        • 8.5.6. Rest of Asia Pacific

      9. Latin America, Middle East and Africa Human Growth Hormone Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 9.1. Key Findings / Summary
      • 9.2. Market Analysis, Insights and Forecast – By Route of Administration
        • 9.2.1. Intravenous
        • 9.2.2. Subcutaneous
        • 9.2.3. Intramuscular
        • 9.2.4. Oral
      • 9.3. Market Analysis, Insights and Forecast – By Distribution Channel
        • 9.3.1. Hospital Pharmacy
        • 9.3.2. Retail Pharmacy
        • 9.3.3. Online Pharmacy
        • 9.3.4. Clinics
      • 9.4. Market Analysis, Insights and Forecast – By Indication
        • 9.4.1. Growth Hormone Deficiency
        • 9.4.2. Turner Syndrome
        • 9.4.3. Idiopathic Short Stature
        • 9.4.4. Prader-Willi Syndrome
        • 9.4.5. Other
      • 9.5. Market Analysis, Insights and Forecast – By Country
        • 9.5.1. Brazil
        • 9.5.2. Saudi Arabia
        • 9.5.3. UAE
        • 9.5.4. Rest of LAMEA

      10. Competitive Analysis

      • 10.1. Company Market Share Analysis, 2018
      • 10.2. Key Industry Developments
      • 10.3. Company Profile
      • 10.4. Merck KGaA
        • 10.4.1. Business Overview
        • 10.4.2. Segment 1 & Service Offering
        • 10.4.3. Overall Revenue
        • 10.4.4. Geographic Presence
        • 10.4.5. Recent Development
      *Similar details will be provided for the following companies
      • 10.5. Pfizer Inc.
      • 10.6. Eli Lilly and Company
      • 10.7. Novartis AG
      • 10.8. Novo Nordisk A/S
      • 10.9. Anhui Anke Biotechnology (Group) Co., Ltd
      • 10.10. Biopartners GmbH
      • 10.11. Ipsen S.A
      • 10.12. GeneScience Pharmaceuticals Co., Ltd.

      Report You Might be Interested

      Choose License Type

      • USD
      • GBP
      • EURO
      • INR
      Credit card Logo

      Happy To Assist You

      Have a Question? email us at

      info@datalibraryresearch.com

      Or Call Us On

      US +1 360 851 1343

      IND +91 880 579 4934